University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
42 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Washington (UoW) is an educational institution that provides undergraduate, postgraduate and masters degrees. The university offers courses in the areas of accounting, aeronautics, applied mathematics, bioengineering, business, social sciences, science, law, medicine, and public affairs. It also provides services in nursing, health services, astronomy, computer science, molecular biotechnology, and oceanography among others.

University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with d

  
Source:
Document ID
GDPH69146D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
University of Washington, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
University of Washington, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
University of Washington, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
University of Washington, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
University of Washington, Medical Devices Deals, 2010 to YTD 2016101
University of Washington, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016113
University of Washington, Pharmaceuticals &Healthcare, Deal Details1424
  Venture Financing141
    Nexgenia Raises USD0.5 Million in Seed Financing Round141
  Partnerships151
    C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine151
    Juno Therapeutics and Fred Hutchinson Cancer Research Center Enter into Joint Venture161
    Novo Nordisk Enters into Research Agreement with UW Medicine171
    Johnson &Johnson Innovation Enters into Research Agreement with Washington University181
    GenVec Enters into Agreement with Washington University at St. Louis191
    Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington201
    OncoSec Medical Enters into Research Agreement with University of Washington211
    Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis221
    Horizon Discovery Enters Into Co-Development Agreement With University Of Washington231
    Fred Hutchinson Cancer Research Enters Into An Agreement With University of Washington241
    Pfizer Enters Into Collaboration With Washington University252
  Merger271
    Northwest Hospital Merges With UW Medicine271
  Licensing Agreements281
    Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine281
    Optikira Enters into Licensing Agreement with University of California, San Francisco and University of Washington291
    Avalanche Biotech Enters into Licensing Agreement with University of Washington301
    Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules311
    GenetikSignal Enters Into Licensing Agreement With University Of Washington321
    ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside331
    Nexgenia Enters into Licensing Agreement with University of Washington341
    Resolve Therapeutics Enters Into Licensing Agreement With University of Washington351
    AttoDx Enters Into Licensing Agreement With University Of Washington And Seattle BioMed361
    Genocea Enters Into Licensing Agreement With University of Washington And Fred Hutchinson Cancer Research Center371
University of Washington - Key Competitors381
Key Employees391
Locations And Subsidiaries402
  Head Office401
  Other Locations &Subsidiaries402
Appendix421
  Methodology421
  About GlobalData421
  Contact Us421
  Disclaimer421

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Washington-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17176>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Washington - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Washington-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17176>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research